Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David A. Fellows currently holds 2,828 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Fellows has been a net seller of TERN stock. They have purchased $0 and sold $462.2K worth of shares.
David A. Fellows's most recent insider trade was on Feb 1, 2026, when they sold 2,828 shares at $0.00 per share.
David A. Fellows serves as Executive at Terns Pharmaceuticals, Inc. (TERN). They have executed 7 insider transactions totaling $462.2K over their tenure at the company.
David A. Fellows holds the position of Executive at Terns Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David A. Fellows has shown a selling trading pattern, with $0 in total purchases and $462.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David A. Fellows was on Jun 7, 2019, when they sold $15.7M worth of NITE shares. This transaction involved 617,090 shares at $25.50 per share.
David A. Fellows currently owns 2,828 shares of Terns Pharmaceuticals, Inc. (TERN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David A. Fellows's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David A. Fellows has 7 Form 4 filings on record as an insider at Terns Pharmaceuticals, Inc..
Set alerts for David A. Fellows and 40,000+ other insiders.